cyanosis and cough productive of pink frothy sputum, and chest X-ray (CXR) revealed gross perihilar shadows consistent. with pulmonary oedema. Blood gas analysis revealed pH 7.43, Pa02 44 mmHg, PaC02 33 mmHg breathiRg 50070 oxygen by mask. Cardiovascular parameters are shown in Table 1 . There was a positive fluid balance of 3,300 ml. The salbutamol infusion was ceased, frusemide 40 mg administered intravenously and she was transferred to the Intensive Care Unit (lCU).
The dyspnoea rapidly improved, CVP decreased to 10 cm H20 and Pa02 increased to 80 mmHg on air within hours of cessation of the infusion. There was an associated large diuresis.
Three days after cessation of the infusion she went into labour again and this time was not suppressed. She was delivered of a live baby. Follow-up ECG, CXR and blood gas estimations revealed no abnormality. Case 2 A 23-year-old woman was admitted for treatment of premature labour at 31 weeks' gestation. Her past medical history included asthma treated with nebulised salbutamol when required, but there was no history of cardiac disease.
A salbutamol infusion was commenced, but uterine contractions persisted and over 40 hours 90 mg of salbutamol were administered. There was a positive fluid balance of 900 ml. She had = Measurement not performed * = Patient already receiving IPPV t = F l o 2 = 1.0, 15 cm PEEP also been treated with indomethacin suppositories 50 mg b.d. and two doses of betamethasone 12 mg at 12-hour intervals.
It was then decided to proceed to caesarean section due to prolonged, established labour. At induction of anaesthesia it was noted that ventilation of the lungs required abnormally high airway pressures, and auscultation revealed widespread crepitations. Arterial blood gas estimation revealed Pa02 58 mmHg and PaC02 38 mmHg (FI02=0.5). The caesarean section proceeded and frusemide 40 mg, one unit of packed cells and a syntocinon infusion were administered.
Postoperatively she was extubated but rapidly developed severe respiratory distress. She was transferred to ICU, reintubated and intermittent positive pressure ventilation (IPPV) was commenced. One hundred per cent oxygen and positive end expiratory pressure (PEEP) 10 cm were required to maintain Pa02 at 70 mmHg. haematology investigations and ECG revealed no abnormality. Chest X-ray demonstrated bilateral infiltrates. A Swan-Ganz catheter was inserted and the pulmonary artery wedge pressure (PA WP) was demonstrated to be 24 mmHg. Cardiac output, measured by thermodilution, was 7 lImin and echo cardiography demonstrated normal left ventricular size and function with no valvular abnormality.
Coagulation studies (including fibrin degradation products [FDP]), biochemistry and
Frusemide 40 mg was administered intravenously and over the next 24 hours she continued to improve with a negative fluid balance of 2.5 litres, a decrease in PA WP to 12 mmHg and marked improvement in gas exchange. She was well enough to be extubated the following day, and was discharged from hospital four days later. Case 3 A 26-year-old woman, with no significant past medical history, presented in premature labour in the 27th week of pregnancy. On admission clinical examination revealed no abnormality.
She was commenced on a salbutamol infusion; two doses of betamethasone 12 mg were administered at 12-hourly intervals, and indomethacin suppositories 50 mg b.d. commenced. She continued to have intermittent uterine contractions and the salbutamol was continued.
On the third day after a total dose of 72 mg salbutamol, she developed orthopnoea, shortness of breath and cough productive of pink, frothy sputum. Cardiovascular measurements are shown in Table 1 . Blood gas estimations (breathing air) revealed pH 7.45, Pa02 45 mmHg and PaC02 31 mmHg. Chest X-ray revealed a dense alveolar exudate consistent with pulmonary oedema. ECG showed sinus tachycardia.
Measurement of electrolytes, glucose, full blood count and coagulation studies revealed no abnormality. There was a positive fluid balance of 5,300 ml over the three days of treatment.
Oxygen was administered by mask, the salbutamol infusion was ceased and frusemide administered intravenously. Her symptoms rapidly resolved, but oxygen was required for a further 24 hours.
Due to continuing uterine contractions, labour was subsequently suppressed with an alcohol infusion. She was delivered of a live male infant in the 36th week of pregnancy.
Case 4
A 28-year-old woman presented in premature labour in the 27th week of her fifth pregnancy. Oral salbutamol 4 mg q.i.d. was commenced and continued for 8 weeks, during which time she had intermittent vaginal bleeding and uterine contractions. A total of 832 mg of salbutamol was administered.
It was then decided to proceed to caesarean section and the salbutamol was ceased. Operation was complicated by considerable blood loss and immediate re-operation and bilateral ligation of the internal iliac arteries was required. Estimated blood loss was 4,800 ml and this was replaced with 5,100 ml fluid (4,100 ml colloid-containing fluids). She was extubated, but rapidly developed severe respiratory distress and on re-intubation copious pink, frothy sputum discharged from the endotracheal tube. Systolic blood pressure dropped to 50 mmHg and a dopamine infusion was commenced. Arterial blood gas estimation, FI02 1.0 and with 15 cm PEEP, revealed Pa02 70 mmHg, PaC02 44 mmHg. Chest X-ray demonstrated bilateral opacification typical of pulmonary oedema. There was no cardiomegaly. Hb was 10.0 g/l00 ml. Fibrinogen and FDP levels were normal. ECG showed sinus tachycardia and echocardiography revealed no valvular abnormality and no gross abnormality of left ventricular function. She was transferred to ICV where the pulmonary artery wedge pressure was demonstrated to be 8 mmHg. The alveolar fluid to serum protein ratio was 0.78. Cardiac output measured by thermodilution was 6 lImin. The dopamine infusion was ceased. IPPV was continued with 100070 02 and 15 cm PEEP and after 12 hours Fj02 could be reduced to 0.5. Thereafter, she improved slowly but progressively and was extubated on the fifth postoperative day.
Case 5
A previously well 26-year-old woman presented with premature labour in the 26th week of pregnancy. There was no history of cardiac or respiratory disease and physical examination on admission revealed no abnormality. She was commenced on an intravenous infusion of salbutamol and two doses of betamethasone 12 mg were administered intramuscularly. After 46 hours, she became dyspnoeic with a respiratory rate of 40/min and cough productive of pink, frothy sputum.
Blood gas analysis revealed Pa02 to be 53 mmHg breathing 50% 02. Chest X-ray revealed bilateral infiltrates consistent with pulmonary oedema. ECG was normal. There was a positive fluid balance of 2.0 litres. The salbutamol was ceased, she was treated with oxygen by mask and frusemide was administered to produce a diuresis of 2,500 ml. Her symptoms rapidly resolved and further episodes of premature labour were suppressed with intravenous alcohol.
DISCUSSION
Although a number of cases of pulmonary oedema associated with f3-tocolytic therapy have been reported,2 there have been few attempts at constructive analysis of why this should occur. This reported group of five patients highlights the diversity of those who develop the syndrome. Salbutamol was administered both orally and by continuous infusion with a wide range of infusion rates, total dosages and durations of treatment. Three developed pulmonary oedema while receiving salbutamol, but in the other two patients it only became evident after cessation of treatment.
In fact the only common factors are the pregnant state, the administration of f32-adrenergic agents, rapid and complete recovery, and no other explanation for the occurrence of pulmonary oedema.
The possible mechanisms have been reviewed 2 and include pre-existing heart disease, the coincident development of peripartum cardiomyopathy, the normal cardiovascular changes of pregnancy associated with the cardiovascular changes of f32-adrenergic agents, specific effects of these drugs, fluid overload, effects of corticosteroid and indomethacin administration and a direct effect of the drug on the pulmonary capillary membrane.
The rapid and complete recovery of three patients and normal echocardiography in two tends to exclude the possibility of pre-existing heart disease or the cardiomyopathy of pregnancy. Large positive fluid balances secondary to infusion of large volumes of 5070 dextrose were present in three of the five patients and fluid overload is likely to be a contributing factor, as may be the administration of corticosteroids in four patients, and indomethacin in three.
The contribution of specific effects of catecholamines is not resolved by reference to these five patients.
The possibility that f32-adrenergic drugs have a direct effect 0ll the pulmonary capillary membrane also remains unclear. In the cases reported above, patients 1, 3 and 5 demonstrated a clinical picture consistent with hydrostatic pulmonary oedema as judged by a rapid and complete clinical response to diuretic therapy, with resultant clearing of the chest X-ray. Measurements of pulmonary artery wedge pressure were, however, not made. In these patients the pulmonary oedema was benign.
Patients 2 and 4, however, developed pulmonary oedema with a fulminating course, and the severity of the hypoxaemia together with the slower resolution, both clinically and radiologically, support the existence of a pulmonary capillary leak or permeability pulmonary oedema. Patient 2 demonstrated a high initial pulmonary artery wedge pressure (24 mmHg), while in patient 4, the measurement was low (8 mmHg). In this patient the alveolar fluid to serum protein ratio was 0.78, confirming the presence of a pulmonary capillary protein leak. It should be noted that this patient suffered other "insults" known to predispose to the adult respiratory distress syndrome (ARDS), namely hypotension and massive blood transfusion. There was, however, no evidence of DIC and no history of aspiration or sepsis.
Work in animals suggests fenoterol can induce non-cardiogenic pulmonary oedema,3 and this should be considered in the light of recent work 4 advocating the use of terbutaline in the treatment of ARDS.
It is most likely that the cardiovascular adaptations of pregnancy associated with the additional high output changes of f32-adrenergic agents produce a state in -which varied but normally minor stress may precipitate pulmonary oedema.
